Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies
The last two decades of cancer research have been devoted in two directions: (1) understanding the mechanism of carcinogenesis for an effective treatment, and (2) improving cancer prevention and screening for early detection of the disease. This last aspect has been developed, especially for certain types of cancers, thanks also to the introduction of new concepts such as liquid biopsies and precision medicine. In this context, there is a growing interest in the application of alternative and noninvasive methodologies to search for cancer biomarkers. The new frontiers of the research lead to a search for RNA molecules circulating in body fluids. Searching for biomarkers in extracellular body fluids represents a better option for patients because they are easier to access, less painful, and potentially more economical. Moreover, the possibility for these types of samples to be taken repeatedly, allows a better monitoring of the disease progression or treatment efficacy for a better intervention and dynamic treatment of the patient, which is the fundamental basis of personalized medicine. RNA molecules, freely circulating in body fluids or packed in microvesicles, have all the characteristics of the ideal biomarkers owing to their high stability under storage and handling conditions and being able to be sampled several times for monitoring. Moreover, as demonstrated for many cancers, their plasma/serum levels mirror those in the primary tumor. There are a large variety of RNA species noncoding for proteins that could be used as cancer biomarkers in liquid biopsies. Among them, the most studied are microRNAs, but recently the attention of the researcher has been also directed towards Piwi-interacting RNAs, circular RNAs, and other small noncoding RNAs. Another class of RNA species, the long noncoding RNAs, is larger than microRNAs and represents a very versatile and promising group of molecules which, apart from their use as biomarkers, have also a possible therapeutic role. In this review, we will give an overview of the most common noncoding RNA species detectable in extracellular fluids and will provide an update concerning the situation of the research on these molecules as cancer biomarkers.
Citations by journals
2
4
6
8
10
12
14
|
|
Cancers
|
Cancers
14 publications, 11.57%
|
International Journal of Molecular Sciences
|
International Journal of Molecular Sciences
9 publications, 7.44%
|
Biochemical Genetics
|
Biochemical Genetics
3 publications, 2.48%
|
Frontiers in Cell and Developmental Biology
|
Frontiers in Cell and Developmental Biology
3 publications, 2.48%
|
Frontiers in Oncology
|
Frontiers in Oncology
3 publications, 2.48%
|
Epigenomics
|
Epigenomics
2 publications, 1.65%
|
Aging
|
Aging
2 publications, 1.65%
|
Cells
|
Cells
2 publications, 1.65%
|
Non-coding RNA
|
Non-coding RNA
2 publications, 1.65%
|
Frontiers in Pharmacology
|
Frontiers in Pharmacology
2 publications, 1.65%
|
Frontiers in Genetics
|
Frontiers in Genetics
2 publications, 1.65%
|
Clinical Biochemistry
|
Clinical Biochemistry
2 publications, 1.65%
|
Seminars in Cancer Biology
|
Seminars in Cancer Biology
2 publications, 1.65%
|
Journal of Cancer Research and Clinical Oncology
|
Journal of Cancer Research and Clinical Oncology
1 publication, 0.83%
|
Biomarkers in Medicine
|
Biomarkers in Medicine
1 publication, 0.83%
|
Cancer Biotherapy and Radiopharmaceuticals
|
Cancer Biotherapy and Radiopharmaceuticals
1 publication, 0.83%
|
Oncology Letters
|
Oncology Letters
1 publication, 0.83%
|
Endocrines
|
Endocrines
1 publication, 0.83%
|
Technology in Cancer Research and Treatment
|
Technology in Cancer Research and Treatment
1 publication, 0.83%
|
Biomolecules
|
Biomolecules
1 publication, 0.83%
|
Genes
|
Genes
1 publication, 0.83%
|
Proteomes
|
Proteomes
1 publication, 0.83%
|
Frontiers in Microbiology
|
Frontiers in Microbiology
1 publication, 0.83%
|
Frontiers in Molecular Biosciences
|
Frontiers in Molecular Biosciences
1 publication, 0.83%
|
Molecular Cancer
|
Molecular Cancer
1 publication, 0.83%
|
Digestive Diseases and Sciences
|
Digestive Diseases and Sciences
1 publication, 0.83%
|
Cellular and Molecular Biology Letters
|
Cellular and Molecular Biology Letters
1 publication, 0.83%
|
Journal of Experimental and Clinical Cancer Research
|
Journal of Experimental and Clinical Cancer Research
1 publication, 0.83%
|
Irish Journal of Medical Science
|
Irish Journal of Medical Science
1 publication, 0.83%
|
2
4
6
8
10
12
14
|
Citations by publishers
5
10
15
20
25
30
35
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
31 publications, 25.62%
|
Springer Nature
|
Springer Nature
23 publications, 19.01%
|
Elsevier
|
Elsevier
16 publications, 13.22%
|
Frontiers Media S.A.
|
Frontiers Media S.A.
13 publications, 10.74%
|
Wiley
|
Wiley
6 publications, 4.96%
|
Future Medicine
|
Future Medicine
3 publications, 2.48%
|
Spandidos Publications
|
Spandidos Publications
3 publications, 2.48%
|
Hindawi Limited
|
Hindawi Limited
3 publications, 2.48%
|
Impact Journals
|
Impact Journals
2 publications, 1.65%
|
Oxford University Press
|
Oxford University Press
2 publications, 1.65%
|
AME Publishing Company
|
AME Publishing Company
2 publications, 1.65%
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
2 publications, 1.65%
|
Mary Ann Liebert
|
Mary Ann Liebert
1 publication, 0.83%
|
SAGE
|
SAGE
1 publication, 0.83%
|
IOP Publishing
|
IOP Publishing
1 publication, 0.83%
|
Royal Society of Chemistry (RSC)
|
Royal Society of Chemistry (RSC)
1 publication, 0.83%
|
Pleiades Publishing
|
Pleiades Publishing
1 publication, 0.83%
|
BMJ
|
BMJ
1 publication, 0.83%
|
Korean Society of Pathologists
|
Korean Society of Pathologists, 1, 0.83%
Korean Society of Pathologists
1 publication, 0.83%
|
eLife Sciences Publications
|
eLife Sciences Publications
1 publication, 0.83%
|
KeAi Communications Co.
|
KeAi Communications Co.
1 publication, 0.83%
|
5
10
15
20
25
30
35
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.